article thumbnail

Just how bad is Facebook health information? Really bad

World of DTC Marketing

Experiences from current patients do provide some context but too often contain lousy advice. In my opinion, pharma companies should avoid Facebook at all costs. SUMMARY: The health information on Facebook is a danger to anyone who reads it. It was an excellent piece of investigative journalism.

Doctors 197
article thumbnail

The social media problem for healthcare

World of DTC Marketing

SUMMARY: The Facebook whistleblower lawsuit can be summed up in one sentence: Facebook prioritizes engagement above all else because it leads to more profits even if that engagement containing inflammatory information. A year ago, Facebook was making a hard charge to get the pharma business.

Branding 224
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

So much for pharma earning trust back

World of DTC Marketing

Pfizer and Moderna have provided data from their large-scale Phase 3 trials only via news releases , which contained the highly promising news that both vaccines were 90 percent effective or more and have not presented any serious safety concerns. It seems that we were premature to think that pharma is earning trust back.

article thumbnail

Covid comments hurt survivors

World of DTC Marketing

In reviewing social media topics and comments on specific health conditions for clients, I determined that more than 75% of posts contained wrong or inaccurate information. This means there is a significant opportunity for pharma to get closer to their audience by helping them understand health problems.

Branding 218
article thumbnail

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Pharmaceutical Technology

Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. This is a primary factor for the staggeringly high unit cost of CGT.

article thumbnail

Leading pharmaceutical benefit managers and management companies

Pharmaceutical Technology

The information contained in the download document is intended for benefit managers, executives, manufacturers, distributors, suppliers, health insurers, product development scientists, and other individuals involved in the pharmaceutical industry. . · Implementation services, and. Claim process management.

Pharmacy 100
article thumbnail

FDA greenlights new long-term treatment option for opioid use disorder

Pharmaceutical Technology

Whilst the pharma industry has been relatively slow in developing new treatments – an array of legal challenges posed to pharma companies and pharmacies implicated in the crisis still trundles on. The year 2023 has seen some landmark regulatory developments to contain the crisis.